65 related articles for article (PubMed ID: 12360571)
1. Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024).
Racette BA; Stambuk M; Perlmutter JS
Mov Disord; 2002 Sep; 17(5):1098-100. PubMed ID: 12360571
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
[TBL] [Abstract][Full Text] [Related]
3. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
Bihari K
Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
[TBL] [Abstract][Full Text] [Related]
4. Supramaximal doses of botulinum toxin for refractory blepharospasm.
Levy RL; Berman D; Parikh M; Miller NR
Ophthalmology; 2006 Sep; 113(9):1665-8. PubMed ID: 16828511
[TBL] [Abstract][Full Text] [Related]
5. [Progression of botulinum toxin type A dosage in craniocervical dystonias. An eight year comparative study].
Echeverría Urabayen A; Fanjul S; Meseguer E; García Ruiz Espiga PJ
Rev Neurol; 2004 Mar 16-31; 38(6):511-3. PubMed ID: 15054712
[TBL] [Abstract][Full Text] [Related]
6. Videonystagmography to assess eyelid dynamic disorders.
Casse G; Adenis JP; Sauvage JP; Robert PY
Orbit; 2009; 28(1):20-4. PubMed ID: 19229740
[TBL] [Abstract][Full Text] [Related]
7. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
Badarny S; Susel Z; Honigman S
Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
[TBL] [Abstract][Full Text] [Related]
8. What is new in the era of focal dystonia treatment? Botulinum injections and more.
Cetinkaya A; Brannan PA
Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.
Truong D; Comella C; Fernandez HH; Ondo WG;
Parkinsonism Relat Disord; 2008; 14(5):407-14. PubMed ID: 18325821
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin management of upper facial rhytidosis and blepharospasm.
Seiff SR; Zwick OM
Otolaryngol Clin North Am; 2005 Oct; 38(5):887-902. PubMed ID: 16214565
[No Abstract] [Full Text] [Related]
11. Botulinum toxin in the treatment of dystonias--a hospital based study.
Gupta M; Singh G; Khwaja G
J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
[TBL] [Abstract][Full Text] [Related]
12. [Botulinum: fashionable drug and effective medication. What the "miracle weapon against crow's feet" can do in addition].
Stiefelhagen P
MMW Fortschr Med; 2003 Apr; 145(14):4-6. PubMed ID: 15072266
[No Abstract] [Full Text] [Related]
13. Impact on quality of life of botulinum toxin treatments for essential blepharospasm.
MacAndie K; Kemp E
Orbit; 2004 Dec; 23(4):207-10. PubMed ID: 15590520
[TBL] [Abstract][Full Text] [Related]
14. [Oromandibular dystonia and botulinum toxins].
Van Durme B; Loeb I; Van Reck J
Acta Stomatol Belg; 1996 Mar; 93(1):37-41. PubMed ID: 9005716
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm.
Ochudlo S; Bryniarski P; Opala G
Parkinsonism Relat Disord; 2007 Dec; 13(8):505-8. PubMed ID: 17543569
[TBL] [Abstract][Full Text] [Related]
16. Unilateral injection of botulinum toxin in blepharospasm: single fiber electromyography and blink reflex study.
Girlanda P; Quartarone A; Sinicropi S; Nicolosi C; Messina C
Mov Disord; 1996 Jan; 11(1):27-31. PubMed ID: 8771064
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period.
Hsiung GY; Das SK; Ranawaya R; Lafontaine AL; Suchowersky O
Mov Disord; 2002 Nov; 17(6):1288-93. PubMed ID: 12465070
[TBL] [Abstract][Full Text] [Related]
18. [Applications of the botulinum A toxin].
Zajácz M
Orv Hetil; 2003 May; 144(18):837-42. PubMed ID: 12785236
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of dystonia in Japan].
Mezaki T; Hayashi A; Nakase H; Hasegawa K
Rinsho Shinkeigaku; 2005 Sep; 45(9):634-42. PubMed ID: 16248394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
